Passaic Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1M Buy
120,076
+1,463
+1% +$218K 1.4% 14
2026
Q1
$17.4M Sell
118,613
-10,000
-8% -$1.54M 1.63% 9
2025
Q4
$19.9M Sell
128,613
-6,177
-5% -$925K 2.06% 10
2025
Q3
$18.8M Buy
134,790
+34,369
+34% +$4.65M 2.26% 6
2025
Q2
$13.5M Sell
100,421
-1,017
-1% -$137K 1.64% 10
2025
Q1
$14.8M Sell
101,438
-19,346
-16% -$2.81M 2.25% 7
2024
Q4
$16.6M Buy
120,784
+23,419
+24% +$3.43M 2.41% 10
2024
Q3
$15M Buy
+97,365
New +$14.8M 2.24% 8
2023
Q4
Sell
-90,570
Closed -$11.7M 10
2023
Q3
$11.7M Sell
90,570
-6,880
-7% -$913K 2.12% 8
2023
Q2
$12.9M Buy
+97,450
New +$12.8M 2.21% 8

Other funds holding XLV

Passaic Partners's XLV Position: Q2 2026 in Review

Passaic Partners increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 1.2% in Q2 2026, buying an estimated $218K and bringing the position to 120,076 shares worth $19.1M. The position accounts for 1.4% of the portfolio, ranked #14.

Passaic Partners first reported a position in XLV in Q2 2023 and has held it in 10 quarters since. The position peaked at $19.9M in Q4 2025. 1,863 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Passaic Partners held 120,076 shares of State Street Health Care Select Sector SPDR ETF worth $19.1M as of Q2 2026.
  • Passaic Partners bought 1,463 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $218K.
  • State Street Health Care Select Sector SPDR ETF made up 1.4% of Passaic Partners's portfolio in Q2 2026, its #14 holding.
  • Passaic Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2023 and has held it in 10 quarters since.
  • Passaic Partners's State Street Health Care Select Sector SPDR ETF position peaked at $19.9M in Q4 2025.
  • 1,863 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Passaic Partners's 13F filing for Q2 2026, filed 14 Aug 2026.